TomoWave Laboratories Company Research Report

Company Overview

Name and Mission

• Company Name: TomoWave Laboratories

• Mission: To contribute to human welfare through leading optoacoustic research and developing solutions that advance medicine and the biomedical sciences. TomoWave strives to pursue partnerships and collaborations within areas of medicine where optoacoustic technologies may best serve patient health. Additionally, they aim to maintain a supportive work environment and produce novel, cost-effective imaging products based on optoacoustic principles.

Founding Details

• Founder: Dr. Alexander A. Oraevsky

• Year Founded: 2010

Key People

• Alexander A. Oraevsky, PhD: Chief Executive Officer and Chief Technology Officer

• Alexander C. Wallstein, MEE, MBA: Acting Chief Operating Officer

• Aleksey N. Krylov, CFA: Acting Chief Financial Officer

• Jim Wu, MD, MBA: Director of Business Development

Headquarters

• Location: 7705 Fannin Street, Suite 500, Houston, TX 77054

Number of Employees

• No exact number of employees is available.

Revenue

• No information is available.

Core Competence

• Known For: Development of proprietary optoacoustic tomography and laser ultrasound systems for combined functional, molecular, and anatomical imaging with applications in cancer detection and image-guided interventions.

Products

LOIS-3D

• Description: Laser Optoacoustic Imaging System (LOIS-3D) for quantitative optoacoustic tomography of live mouse body and brain.

• Key Features:

• Provides comprehensive volumetric optoacoustic tomography.

• Delivers anatomical, functional, and molecular imaging with high accuracy.

MAESTRO-MD

• Description: Universal Premium High-End System for clinical applications.

• Key Features:

• Dual-modality system combining ultrasound and optoacoustics.

• Handles a wide range of clinical applications including cancer detection, therapeutic monitoring, and image-guided surgery.

• Costs are minimized for its advanced functionalities.

SYMPHONY

• Description: A system for comprehensive breast cancer imaging.

• Key Features:

• Provides 3D optoacoustic functional anatomical scans, supplemented by hand-held probes.

• Competes with MRI offering a safer and more cost-effective alternative.

• Includes capabilities for hyperthermia treatment.

Recent Developments

Recent Innovations

• Technology Development:

• Advancement to latest optoacoustic technology combined with ultrasound for enhanced imaging solutions.

Partnerships

• Collaborations with MD Anderson Cancer Center in Houston and more cancer centers at University of California, San Diego, among others.

Product Launches

• Innovations in 3D Imaging:

• The introduction of TomoWave systems for 3D quantitative optoacoustic tomography particularly for small animal imaging.

Financial Developments

• Investment: Currently involved in Series A equity funding to accelerate sales pipeline, commercial development and regulatory approvals.

Intellectual Property

• Patent Status: Protected by 8 international patent families and multiple patent applications.

Contact Information

• TomoWave Laboratories, Inc.

• 7705 Fannin Street, Suite 500, Houston, TX 77054

• Skype: TomoWave2010

• Email: general@tomowave.com

This report covers the essential elements of TomoWave Laboratories as an innovative leader in optoacoustic imaging technologies, detailing key methodologies, products, leadership, and recent developments within the company framework.